Lately, various traumatic brain injury advocates have assisted in getting
the Advancing Research for Neurological Diseases Act further in the U.S.
Senate than ever before. Under this bill, a data collection system used
to keep track of the occurrences of neurological diseases and brain injuries
will be established. Many believe that this progression will allow new
therapies to arise, which can provide remedies and treatments for people
suffering from the following:
- Brain injury
- Multiple Sclerosis
In addition, new studies find that this progression has led medical professionals
to nearly achieve personalized medication, which will take into account
patients’ environmental, lifestyle, and unique genetic factors.
If passed by legislation, biomedical research can be streamlined and modernized,
which can lead to effective treatments for a countless number of Americans.
Together, these efforts can provide a new foundation for the way medical
professionals understand and evaluate all areas of neurological diseases,
which can, in turn, expedite the journey to finding cures.
In February, the United States Senate’s Health, Education, Labor,
and Pensions Committee passed this act. The act was then filed as an amendment
to the Senates’ National Defense Authorization Act. On June 15,
Senate passed the act, but it did not include S. 849. As of now, the Brain
Injury Association of America is committed to staying persistent in advancing
the Advancing Research for Neurological Diseases Act.